In 2004, MRSA accounted for 94 percent of all healthcare-associated infections per 1,000 patient bed days in the Pittsburgh Veterans Administration Health System. Precautions and education about the disease have lowered incidents significantly, but reports of new outbreaks of this health hazard still appear in the news regularly.
In earlier chip development research, IBM researchers identified specific materials that, when chained together, produced an electrostatic charge that allows microscopic etching on a wafer to be done at a much smaller scale.
This newfound knowledge that characterization of materials could be manipulated at the atomic level to control their movement inspired the team to see what else they could do with these new kinds of polymer structures. They started with MRSA.
The outcome of that experiment was the creation of what are now playfully known as “ninja polymers” – sticky nanostructures that move quickly to target infected cells in the body, destroy the harmful content inside, and then disappear by biodegrading without causing damaging side effects or accumulating in the organs.